Nordicus Partners Corporation

corporate_fare Company Profile

Nordicus Partners Corporation

NORD·OTC·Trade & Services·CIK 0001492966

Nordicus Partners Corporation operates as a publicly traded business accelerator and holding company for Nordic life sciences companies in the United States. The company focuses on developing medicines supporting oral health. It also provides corporate finance activities, which include business and market development, growth strategies, talent acquisition, partnership building, capital raising, and facilitating company acquisitions and sales. Nordicus Partners Corporation was formerly known as EKIMAS Corporation and changed its name in May 2023. The company was founded in 1993 and is based in Beverly Hills, California.

Nordicus Partners Corporation (OTC:NORD) is a publicly traded company in the Trade & Services sector. Wiseek monitors NORD SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

Nordicus Partners Closes $554K Private Placement at $2.75 Per Share (2026-06-23)

Insider Transactions

NORD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with N →

show_chartPrice Chart

Loading chart...

feed NORD - Latest Insights

Filing Type

Date Range

NORD

Jun 23, 2026, 3:40 PM EDT

Filing Type: 8-K

Importance Score:

Nordicus Partners Closes $554K Private Placement at $2.75 Per Share

Price at Filing: $1.66

Real-time Price: $1.90

Change: +$0.239 (+14%)

Market Cap: $35.888M

Sentiment: Neutral

View Wiseek Article

corporate_fare Company Profile